Role of the β-amyloid protein in Alzheimer's disease

Sangram S. Sisodia, Donald L. Price

Research output: Contribution to journalReview articlepeer-review

215 Scopus citations


A major histopathological hallmark of Alzheimer's disease (AD) is the presence of amyloid deposits in the parenchyma of the amygdala, hippocampus, and neocortex. The principal component of amyloid is the β-amyloid protein (Aβ), a 39-43 amino acid peptide composed of a portion of the transmembrane domain and the extracellular domain of the amyloid precursor protein (APP). APP occurs as several Aβ-containing isoforms of 695, 751, and 770 amino acids, with the latter two APP containing a domain that shares structural and functional homologies with Kunitz serine protease inhibitors. In cultured cells, APP mature through the constitutive secretory pathway, and some cell surface-bound APP are cleaved by an enzyme, designated as α-secretase, within the Aβ domain, an event that precludes Aβ amyloidogenesis. Several studies have delineated two additional pathways of APP processing: first, an endosomal/lysosomal pathway generates a complex set of APP-related membrane- bound fragments, some of which contain the entire Aβ sequence; and, second, by mechanisms which are not fully understood, Aβ1-40 is secreted into the conditioned medium in vitro and is present in cerebrospinal fluid in vivo. The intracellular sites of enzymes responsible for proteolytic cleavage at the NH2 and COOH termini of Aβ, termed γ- and β-secretase, respectively, have not been identified. Finally, recent molecular genetic investigations have identified a variety of mutations in APP that segregate with early- onset familial AD and with hereditary cerebral hemorrhage with amyloid, Dutch type (HCHWA-D). Several of these mutations appear to influence APP processing and result in the production of higher levels or longer Aβ-related peptides that are inherently more fibrillogenic. Although a variety of lines of evidence implicates APP/Aβ in AD, the mechanisms by which Aβ influences the biology and vulnerability of neural cells are not fully understood but are very active areas of investigation. This review focuses on the present state of our understanding of APP and Aβ in the context of AD.

Original languageEnglish (US)
Pages (from-to)366-370
Number of pages5
JournalFASEB Journal
Issue number5
StatePublished - 1995


  • APP processing
  • FAD mutations
  • apoE
  • toxicity

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics


Dive into the research topics of 'Role of the β-amyloid protein in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this